ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CRBU Caribou Biosciences Inc

5.13
0.01 (0.20%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,347,717
Bid Price 5.07
Ask Price 5.13
News -
Day High 5.228

Low
3.44

52 Week Range

High
8.5899

Day Low 5.065
Company Name Stock Ticker Symbol Market Type
Caribou Biosciences Inc CRBU NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 0.20% 5.13 17:41:01
Open Price Low Price High Price Close Price Prev Close
5.15 5.065 5.228 5.14 5.12
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,478 1,347,717 $ 5.13 $ 6,919,186 - 3.44 - 8.5899
Last Trade Time Type Quantity Stock Price Currency
19:32:53 2 $ 5.13 USD

Caribou Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
463.31M 90.31M - 13.85M -99.42M -1.10 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Caribou Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CRBU Message Board. Create One! See More Posts on CRBU Message Board See More Message Board Posts

Historical CRBU Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.585.775.055.211,401,668-0.45-8.06%
1 Month8.128.224.995.841,824,506-2.99-36.82%
3 Months5.248.334.696.081,619,242-0.11-2.10%
6 Months4.698.333.445.501,598,0980.449.38%
1 Year4.678.58993.445.751,865,3880.469.85%
3 Years17.6532.6453.448.171,102,221-12.52-70.93%
5 Years17.6532.6453.448.171,102,221-12.52-70.93%

Caribou Biosciences Description

Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

Your Recent History

Delayed Upgrade Clock